You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chronic spontaneous urticaria

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenosine Deaminase and Immunoglobulin E in Chronic Spontaneous

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • Adenosine deaminase serum level
  • IgE antibodies serum level
  • (no location specified)
Aug 7, 2023

Chronic Spontaneous Urticaria Trial in Dublin (ABT Online Programme, Delayed Control group)

Suspended
  • Chronic Spontaneous Urticaria
  • ABT Online Programme
  • Delayed Control group
  • Dublin, Ireland
    St James's Hospital
Oct 25, 2023

Xolair® in Pediatric Chronic Spontaneous Urticaria in China

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • Xolair
  • (no location specified)
Sep 19, 2023

Urticaria, Chronic Spontaneous Urticaria, Chronic Idiopathic Urticaria Trial (Povorcitinib, Placebo)

Not yet recruiting
  • Urticaria
  • +5 more
  • (no location specified)
Jul 6, 2023

Chronic Spontaneous Urticaria, Chronic Urticaria, Idiopathic Trial in Copenhagen (omalizumab 300 mg every four weeks, omalizumab

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • Chronic Urticaria, Idiopathic
  • omalizumab 300 mg every four weeks
  • omalizumab 300 mg every six weeks
  • Copenhagen, Copenhagen N, Denmark
    Department of Dermatology, Bispebjerg Hospital
Jun 21, 2023

Healthy Participants, Chronic Spontaneous Urticaria Trial in Anniston (AK006, Placebo)

Recruiting
  • Healthy Participants
  • Chronic Spontaneous Urticaria
  • Anniston, Alabama
    Site 601-001 Healthy Volunteer Clinical Research Unit
Oct 2, 2023

Chronic Spontaneous Urticaria Trial in Jacksonville (Nucala)

Recruiting
  • Chronic Spontaneous Urticaria
  • Jacksonville, Florida
    Mayo Clinic in Florida
Nov 30, 2022

Xolair (OMALIZUMAB) in Chronic Spontaneous Urticaria

Recruiting
  • Spontaneous Urticaria, Chronic
    • Lille, France
      Hop Claude Huriez Chu Lille
    Jan 25, 2023

    Chronic Spontaneous Urticaria Trial (LOU064)

    Not yet recruiting
    • Chronic Spontaneous Urticaria
    • (no location specified)
    Mar 21, 2023

    Chronic Spontaneous Urticaria Trial in Canada, United States (Oral EP262, Placebo)

    Recruiting
    • Chronic Spontaneous Urticaria
    • Oral EP262
    • Placebo
    • Birmingham, Alabama
    • +7 more
    Oct 5, 2023

    Chronic Spontaneous Urticaria Trial (Remibrutinib, Placebo to remibrutinib, Placebo to omalizumab)

    Not yet recruiting
    • Chronic Spontaneous Urticaria
    • (no location specified)
    Sep 20, 2023

    Chronic Spontaneous Urticaria (CSU) Trial (LOU064 (blinded), Placebo, LOU064 (open label))

    Not yet recruiting
    • Chronic Spontaneous Urticaria (CSU)
    • LOU064 (blinded)
    • +2 more
    • (no location specified)
    Aug 22, 2022

    Chronic Spontaneous Urticaria Trial (Cohort 1: TLL018 tablets, Cohort 2: TLL018 tablets, Cohort 3: TLL018 tablets)

    Not yet recruiting
    • Chronic Spontaneous Urticaria
    • Cohort 1: TLL018 tablets
    • +2 more
    • (no location specified)
    May 10, 2022

    Chronic Spontaneous Urticaria Trial (Ligelizumab)

    No longer available
    • Chronic Spontaneous Urticaria
    • (no location specified)
    May 6, 2022

    Chronic Spontaneous Urticaria Trial in Japan (TAS5315 Dose 1, TAS5315 Dose 2, TAS5315 Dose 3)

    Recruiting
    • Chronic Spontaneous Urticaria
    • TAS5315 Dose 1
    • +5 more
    • Fukuoka, Japan
    • +4 more
    Aug 15, 2022

    Healthy Study Participants, Chronic Spontaneous Urticaria Trial in Sofia (UCB8600, Placebo)

    Terminated
    • Healthy Study Participants
    • Chronic Spontaneous Urticaria
    • Sofia, Bulgaria
      Up0086 001
    Jul 15, 2022

    Chronic Spontaneous Urticaria Trial in Germany, United States (CDX-0159, Normal Saline)

    Completed
    • Chronic Spontaneous Urticaria
    • Birmingham, Alabama
    • +13 more
    Jan 24, 2023

    Chronic Spontaneous Urticaria Trial (LOU064 (blinded), )

    Not yet recruiting
    • Chronic Spontaneous Urticaria
    • LOU064 (blinded)
    • placebo
    • (no location specified)
    Dec 23, 2022

    Chronic Spontaneous Urticaria Trial (Remibrutinib)

    Available
    • Chronic Spontaneous Urticaria
    • (no location specified)
    Dec 9, 2021

    STOP CSUA: phySical acTivity, mOod and sleeP in Chronic

    Not yet recruiting
    • Chronic Spontaneous Urticaria
    • Physical activity monitoring - Symptom monitoring
    • Dublin, Ireland
      St. James's Hospital
    Dec 13, 2021

    Chronic Spontaneous Urticaria, Recurrent Angioedema Trial in Germany (Dupilumab, Placebo)

    Completed
    • Chronic Spontaneous Urticaria
    • Recurrent Angioedema
    • Marburg, Hessen, Germany
    • +5 more
    Feb 1, 2022

    Chronic Spontaneous Urticaria Trial in Worldwide (Benralizumab, Placebo and Benralizumab)

    Active, not recruiting
    • Chronic Spontaneous Urticaria
    • Benralizumab
    • Placebo and Benralizumab
    • Scottsdale, Arizona
    • +39 more
    Jan 16, 2023

    Chronic Spontaneous Urticaria Trial in Japan (LOU064)

    Recruiting
    • Chronic Spontaneous Urticaria
    • Nagoya, Aichi, Japan
    • +11 more
    Jul 14, 2022

    Allergic Disease, Chronic Spontaneous Urticaria, Chronic Inducible Urticaria Trial in Seongnam-si, Suwon-si, Seoul (YH35324,

    Recruiting
    • Allergic Disease
    • +3 more
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
    • +4 more
    Jul 24, 2023

    Chronic Spontaneous Urticaria Trial in Warszawa (CT-P39, EU-approved Xolair)

    Recruiting
    • Chronic Spontaneous Urticaria
    • CT-P39
    • EU-approved Xolair
    • Warszawa, Poland
      Klinika Ambroziak ESTEDERM
    Aug 25, 2021